Ace Therapeutics
Preclinical Hepatology CRO Services
Get Free Quote

Preclinical Hepatology CRO Services

Inquiry

With our specialized focus on hepatology, Ace Therapeutics offers a wide range of comprehensive solutions to support your research and development needs in this field. Our team of experts is dedicated to helping clients conduct in-depth disease mechanism research, drug development, diagnostic technology development, and more. Whether you need assistance with liver disease modeling, drug efficacy studies, or toxicity assessments, our team is committed to providing reliable data to drive your hepatology research forward.

What Hepatic Diseases Do We Offer Preclinical Research Services for?

Organ Type
Liver Diseases

Biliary Diseases

Pancreatic Diseases
Ace Therapeutics is a leading provider of expertise in liver disease, offering comprehensive services to our customers. We specialize in developing human-relevant disease models, conducting in-depth research on liver biology and mechanisms, and providing a wide range of preclinical services from target validation to toxicity testing. Ace Therapeutics's experts in biliary disorders can assist customers from targeted research to candidate screening. With a deep understanding of biliary system and pathology, we provide tailored disease models, conduct comprehensive research, and offer a range of preclinical services to support the development of therapeutic interventions. Ace Therapeutics brings valuable expertise in pancreatic pathology research to support programs focused on pancreatic biology and pathology. Our services encompass tailored disease models and multi-scale techniques, providing comprehensive support for early discovery and in-depth research, including areas such as pancreatic cancer and pancreatitis.
Disease Type
  • Alcoholic Liver Disease
  • Hepatitis Disease
  • Fatty Liver Disease
  • Liver Fibrosis Disease
  • Cirrhosis Disease
  • Liver Failure Disease
  • Viral Hepatitis Disease
  • Autoimmune Liver Disease
  • Inherited Liver Disease
  • Cholecystitis
  • Cholangitis
  • Biliary Atresia
  • Gallstone
  • Pancreatitis
  • Pancreatic Microcirculation Disorder

What Can We Do for Preclinical Hepatology Research?

Disease Modeling Disease Mechanism Research Drug Development Diagnostic Technology Development Toxicity Assessment
  • Utilize cell-based models like primary hepatocytes, cell lines, and organoids to study disease mechanisms, drug metabolism, and toxicity.
  • Establish co-culture systems to mimic the liver microenvironment and cell interactions for a more comprehensive understanding of pathology.
  • Induce liver diseases through chemical, genetic, or transplantation methods to model specific conditions and disease progression.
  • Conduct in-depth investigations into the molecular and cellular pathways underlying hepatitis, fibrosis, hepatocellular carcinoma, and other liver diseases.
  • Employ advanced techniques to examine disease progression, immune responses, and metabolic dysregulation to inform therapeutic targeting.
  • Design and execute efficacy studies of candidates using relevant disease models.
  • Evaluate pharmacokinetics, pharmacodynamics, and drug toxicity profiles to guide development decisions.
  • Collaborate on developing diagnostic tools for liver diseases through biomarker identification and validation.
  • Leverage multi-omics, imaging, and bioinformatics to create assays for disease detection and monitoring.
  • Perform comprehensive toxicology evaluations of drug safety profiles and potential adverse effects.
  • Assess acute, subchronic and chronic toxicities to ensure therapeutic safety.

Advantages of Our Preclinical Hepatology CRO Services

  • Multidisciplinary Expertise

Our dedicated team of hepatologists, toxicologists, and biological scientists focuses specifically on liver disease science. This allows us to generate high-quality, translatable data throughout the R&D process.

  • Model Customization

We provide tailored disease models that closely mimic unique human conditions, ensuring research relevance and accuracy for the evaluation of new therapies.

  • One-Stop Solution

Our comprehensive portfolio addresses varied client needs, from target validation and efficacy studies to ADME profiling, toxicity assessments, and beyond.

  • Cutting-Edge Analytics

Advanced analytical techniques like organ-chip platforms, histopathology, and live imaging are leveraged to generate reliable insights and decrease development risks.

At Ace Therapeutics, we are dedicated to supporting your research and development goals in hepatology. Leveraging customized disease models and a multifaceted portfolio of efficacy, safety, and biomarker solutions, our experienced team works to generate high-quality data to advance your programs. Contact us to explore how we can help accelerate timelines and drive new discoveries and therapeutic development in hepatology.

Our products and services are for research use only and can not be used for diagnostic or other purposes.